Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2019-01-22 Earnings Release
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
Bone Therapeutics annonce ses perspectives d’affaires pour 2019 et dresse son bilan de trésorerie
Earnings Release Classification · 98% confidence The document is dated January 22, 2019, and is titled "Bone Therapeutics annonce ses perspectives d'affaires pour 2019 et dresse son bilan de trésorerie" (Bone Therapeutics announces its business outlook for 2019 and provides its cash position). It details expected clinical trial milestones (Phase IIA results, CTA submissions, Phase III start) and reports the cash usage and net cash position as of December 31, 2018. It also includes a financial calendar listing future reports (Annual Report, Q1 results, AGM, H1 results, Q3 results). This content—providing forward-looking business guidance and a summary of recent financial status (cash position) without presenting full audited financial statements—is characteristic of an Earnings Release (ER) or a preliminary business update often released around earnings time. Since it focuses on outlook and cash summary rather than full quarterly results (which are scheduled for later dates like May 7th for Q1 or August 30th for H1), it fits best as an Earnings Release (ER) announcing key highlights and outlook for the coming year. It is not a full 10-K, an Interim Report (IR), or a Call Transcript (CT). It is an announcement of results/outlook, not an announcement of a report publication (RPA). FY 2018
2019-01-22 French
PR_2018-12-24_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change Classification · 98% confidence The document is dated December 24, 2018, and is titled 'Information on the total number of voting rights and shares'. It explicitly details the change in the total number of shares and voting rights due to a recent issuance following the conversion of convertible bonds. This directly relates to changes in the company's capital structure and share count, which is governed by specific regulations (Article 15 of the Belgian Law mentioned). This content aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA), as it reports the resulting share count after a capital event (conversion/issuance). It is not a general earnings release (ER), an interim report (IR), or a proxy statement (PSI).
2018-12-24 English
PR_2018-12-24_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions" (Information relating to the total number of voting rights and shares) and is dated December 24, 2018. It explicitly details the change in the total number of shares and voting rights following the issuance of new shares due to the conversion of convertible bonds. This type of mandatory disclosure, which concerns changes in the capital structure and voting rights, aligns directly with the category for Share Issue/Capital Change (SHA). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific capital event.
2018-12-24 French
PR_2018-12-11_BT_Transparency Notification SRIW_EN_Final.pdf
Major Shareholding Notification Classification · 99% confidence The document is titled 'Transparency notification received from S.R.I.W. SA and Sofipôle SA' and explicitly references 'Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings'. It details the passive crossing of a 10% ownership threshold by specific entities (S.R.I.W. SA and Sofipôle SA) and provides a table summarizing the voting rights before and after the transaction date (14 November 2018). This content directly corresponds to notifications regarding changes in significant share ownership levels, which matches the definition for Major Shareholding Notification (MRQ). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific insider/major shareholder transaction disclosure.
2018-12-11 English
PR_2018-12-11_BT_Transparency Notification SRIW_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a formal announcement dated December 11, 2018, titled "Notification de transparence reçue de la part de S.R.I.W. SA et Sofipôle SA" (Transparency notification received from S.R.I.W. SA and Sofipôle SA). It explicitly references Article 14 of a Belgian law concerning the disclosure of significant shareholdings ('publicité des participations importantes'). The content details that two entities crossed the 10% ownership threshold following a share issuance. This type of filing, which reports changes in significant share ownership crossing predefined thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2018-12-11 French
PR_2018-11-29_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change Classification · 98% confidence The document is titled "Information on the total number of voting rights and shares" and is dated November 29, 2018. It explicitly details the change in the total number of shares with voting rights and the total number of diluted shares due to a recent issuance following convertible bond conversion. This content directly relates to changes in the company's capital structure and share count, which is a specific type of corporate action disclosure. Among the provided codes, 'Share Issue/Capital Change' (SHA) is the most appropriate fit for a formal announcement detailing the resulting share count and capital structure changes, as opposed to a general financing update (CAP) or a transaction in own shares (POS), as this is a result of a prior financing instrument conversion. It is not a general regulatory filing (RNS) because it fits a more specific category.
2018-11-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.